Form 8-K - Current report:
SEC Accession No. 0001171843-17-004701
Filing Date
2017-08-03
Accepted
2017-08-03 16:15:29
Documents
2
Period of Report
2017-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080317.htm 8-K 15483
2 EXHIBIT 99.1 exh_991.htm EX-99.1 45682
  Complete submission text file 0001171843-17-004701.txt   62303
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 171005101
SIC: 2834 Pharmaceutical Preparations